Organogenesis Holdings Stock Market Value
| ORGO Stock | USD 2.63 0.06 2.23% |
| Symbol | Organogenesis |
Organogenesis Holdings Price To Book Ratio
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.307 | Earnings Share 0.04 | Revenue Per Share 3.313 | Quarterly Revenue Growth 0.022 | Return On Assets 0.0201 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Organogenesis Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Organogenesis Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Organogenesis Holdings.
| 02/27/2024 |
| 05/27/2024 |
If you would invest 0.00 in Organogenesis Holdings on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Organogenesis Holdings or generate 0.0% return on investment in Organogenesis Holdings over 90 days. Organogenesis Holdings is related to or competes with China Pharma, China SXT, and SNDL. Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for th... More
Organogenesis Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Organogenesis Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Organogenesis Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 37.5 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 6.13 |
Organogenesis Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Organogenesis Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Organogenesis Holdings' standard deviation. In reality, there are many statistical measures that can use Organogenesis Holdings historical prices to predict the future Organogenesis Holdings' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.10) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Organogenesis Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Organogenesis Holdings Backtested Returns
Organogenesis Holdings maintains Sharpe Ratio (i.e., Efficiency) of -0.0431, which implies the firm had a -0.0431% return per unit of risk over the last 3 months. Organogenesis Holdings exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Organogenesis Holdings' Risk Adjusted Performance of (0.01), coefficient of variation of (3,414), and Variance of 40.8 to confirm the risk estimate we provide. The company holds a Beta of 1.93, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Organogenesis Holdings will likely underperform. Organogenesis Holdings has an expected return of -0.28%. Please make sure to check Organogenesis Holdings value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Organogenesis Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.25 |
Poor predictability
Organogenesis Holdings has poor predictability. Overlapping area represents the amount of predictability between Organogenesis Holdings time series from 27th of February 2024 to 12th of April 2024 and 12th of April 2024 to 27th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Organogenesis Holdings price movement. The serial correlation of 0.25 indicates that over 25.0% of current Organogenesis Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Organogenesis Holdings lagged returns against current returns
Autocorrelation, which is Organogenesis Holdings stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Organogenesis Holdings' stock expected returns. We can calculate the autocorrelation of Organogenesis Holdings returns to help us make a trade decision. For example, suppose you find that Organogenesis Holdings has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Organogenesis Holdings regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Organogenesis Holdings stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Organogenesis Holdings stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Organogenesis Holdings stock over time.
Current vs Lagged Prices |
| Timeline |
Organogenesis Holdings Lagged Returns
When evaluating Organogenesis Holdings' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Organogenesis Holdings stock have on its future price. Organogenesis Holdings autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Organogenesis Holdings autocorrelation shows the relationship between Organogenesis Holdings stock current value and its past values and can show if there is a momentum factor associated with investing in Organogenesis Holdings.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Organogenesis Holdings Correlation, Organogenesis Holdings Volatility and Organogenesis Holdings Alpha and Beta module to complement your research on Organogenesis Holdings. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Organogenesis Stock analysis
When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Organogenesis Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.